Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HALO Diagnostics operates a network of outpatient precision diagnostic centers that combine advanced imaging (MRI/PET/CT), digital pathology, genomics testing—including non-invasive liquid biomarkers—and AI-driven analytics to enable early detection of major diseases such as cancer and cardiovascular conditions. The company’s approach aims to improve survival rates by diagnosing diseases at earlier stages and providing actionable results for personalized treatment plans. They serve over one million patients annually with rapid turnaround times for results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HALO Diagnostics.